Prevalence and Predictors of Adverse Events Associated With Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetic Patients: A Cross-sectional Study.
- DOI
- 10.1177/11795514241288645
- Published
- 2024
- Container
- Clinical medicine insights. Endocrinology and diabetes
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/11795514241288645,
title = {Prevalence and Predictors of Adverse Events Associated With Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetic Patients: A Cross-sectional Study.},
author = {Reghunath SR and Chackochan A and Thunga G and Acharya DU and Shivashankara KN and Ravindra Prabhu A and Acharya LD},
year = {2024},
journal = {Clinical medicine insights. Endocrinology and diabetes},
doi = {10.1177/11795514241288645},
url = {https://doi.org/10.1177/11795514241288645}
}RIS
TY - JOUR TI - Prevalence and Predictors of Adverse Events Associated With Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetic Patients: A Cross-sectional Study. AU - Reghunath SR AU - Chackochan A AU - Thunga G AU - Acharya DU AU - Shivashankara KN AU - Ravindra Prabhu A AU - Acharya LD PY - 2024 JO - Clinical medicine insights. Endocrinology and diabetes DO - 10.1177/11795514241288645 UR - https://doi.org/10.1177/11795514241288645 ER -
APA
SR, R., A, C., G, T., DU, A., KN, S., A, R. P., & LD, A. (2024). Prevalence and Predictors of Adverse Events Associated With Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetic Patients: A Cross-sectional Study.. Clinical medicine insights. Endocrinology and diabetes. https://doi.org/10.1177/11795514241288645
Source records
- pubmed · retrieved 2026-09-26T00:15:33.685Z